10-propargyl-10-deazaaminopterin and Multiple Myeloma

10-propargyl-10-deazaaminopterin has been researched along with Multiple Myeloma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berube, C; Coutré, SE; Dinner, S; Dunn, TJ; Gotlib, J; Hao, Y; Liedtke, M; Medeiros, BC; Price, E	1

Trials

1 trial(s) available for 10-propargyl-10-deazaaminopterin and Multiple Myeloma

Article	Year
A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma. British journal of haematology, 2016, Volume: 173, Issue:2 Topics: Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Treatment Outcome	2016

Article

Year

A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma.

British journal of haematology, 2016, Volume: 173, Issue:2

Topics: Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Treatment Outcome

2016